期刊文献+

Complex pathologies of angiotensin Ⅱ-induced abdominal aortic aneurysms 被引量:3

Complex pathologies of angiotensin Ⅱ-induced abdominal aortic aneurysms
原文传递
导出
摘要 Angiotensin II (Angll) is the primary bioactive peptide of the renin angiotensin system that plays a critical role in many cardiovascular diseases. Subcutaneous infusion of Angll into mice induces the development of abdominal aortic aneurysms (AAAs). Like human AAAs, Angll-induced AAA tissues exhibit progressive changes and considerable heterogeneity. This complex pathology provides an impediment to the quantification of aneurysmal tissue composition by biochemical and immunostaining techniques. Therefore, while the mouse model of Angll-induced AAAs provides a salutary approach to studying the mechanisms of the evolution of AAAs in humans, meaningful interpretation of mechanisms requires consideration of the heterogeneous nature of the diseased tissue. Angiotensin Ⅱ (AngⅡ) is the primary bioactive peptide of the renin angiotensin system that plays a critical role in many cardiovascular diseases.Sub-cutaneous infusion of AngⅡ into mice induces the development of abdominal aortic aneurysms (AAAs).Like human AAAs,AngⅡ-induced AAA tissues exhibit progressive changes and considerable heterogeneity.This complex pathology provides an impediment to the quantification of aneurysmal tissue composition by biochemical and immunostaining techniques.Therefore,while the mouse model of AngⅡ-induced AAAs provides a salutary approach to studying the mechanisms of the evolution of AAAs in humans,meaningful interpretation of mechanisms requires consideration of the heterogeneous nature of the diseased tissue.
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2011年第8期624-628,共5页 浙江大学学报(英文版)B辑(生物医学与生物技术)
基金 Project (Nos. HL062846 and HL80100) supported by the National Institutes of Health of the United States of America
关键词 Abdominal aortic aneurysms Angiotensin II Pathologies MOUSE Abdominal aortic aneurysms Angiotensin Ⅱ Pathologies Mouse
  • 相关文献

参考文献23

  • 1Hackam, D.G., Thiruchelvam, D., Redelmeier, D.A., 2006. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet, 368(9536):659-665. [doi:10.1016/S0140-6736(06)69250-7].
  • 2Deng, G.G., Martin-McNulty, B., Sukovich, D.A., Freay, A., Halks-Miller, M., Thinnes, T., Loskutoff, D.J., Carmeliet, P., Dole, W.P., Wang, Y.X., 2003. Urokinase-type plas- minogen activator plays a critical role in angiotensin Ⅱ- induced abdominal aortic aneurysm. Circ. Res., 92(5): 510-517. [doi:10,1161/01 .RES,0000061571.49375E1].
  • 3Choke, E., Cockerill, G., Wilson, W.R., Sayed, S., Dawson, J., Loftus, I., Thompson, M.M., 2005. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur. J. Vasc. Endovasc. Surg., 30(3):227-244. [doi:10. 1016/j.ejvs.2005.03.009].
  • 4Yoshimura, K., Aoki, H., Ikeda, Y., Fujii, K., Akiyama, N., Furutani, A., Hoshii, Y., Tanaka, N., Ricci, R., Ishihara, T., et al., 2005. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med., 11(12):1330-1338. [doi:10.1038/nm1335].
  • 5Saraff, K., Babamusta, F., Cassis, L.A., Daugherty, A., 2003. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin Ⅱ-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol., 23(9) 1621-1626. [doi:10.1161/01.ATV.0000085631.76095.64].
  • 6Jones, G.T., Thompson, A.R., van Bockxmeer, F.M., Hafez, H., Cooper, J.A., Golledge, J., Humphries, S.E., Norman, P.E., van Rij, A.M., 2008. Angiotensin Ⅱ type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler. Thromb. Vasc. Biol., 28(4):764-770. [doi:10.1161/ ATVBAHA. 107.155564].
  • 7Wang, J.A., Chen, W.A., Wang, Y., Zhang, S., Bi, H., Hong, B., Luo, Y., Daugherty, A., Xie, X., 2011. Statins exert differential effects on angiotensin Ⅱ-induced atheroscle- rosis, but no benefit for abdominal aortic aneurysms. Atherosclerosis, in press. [doi:10.1016/j.atherosclerosis. 2011.03.005].
  • 8Powell, J.T., Brady, A.R., 2004. Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioseler. Thromb. Vase. BioL, 24(2): 241-245. [doi: 10.1161/01.ATV.0000106016.13624.4a].
  • 9Ahluwalia, N., Lin, A.Y., Tager, A.M., Pruitt, I.E., Anderson, T.J., Kristo, F., Shen, D., Cruz, A.R., Aikawa, M., Luster, A.D., et al., 2007. Inhibited aortic aneurysm formation in BLTl-deficient mice. J. Immunol., 179(1):691-697.
  • 10Lu, H., Rateri, D.L., Cassis, L.A., Daugherty, A., 2008. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr. Hypertens. Rep., 10(2):99-106. [doi:10. 1007/s11906-008-0020-3].

同被引文献9

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部